ClinicalTrials.govpublic full text
Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism Risk
excessive supraventricular ectopies or short atrial runs (esvea), atrial fibrillation, rivaroxaban, embolism, short atrial runs (esvea), interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 870141
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.